LabGenius Therapeutics Announces Second Collaboration With Sanofi to Co-Optimise Therapeutic NANOBODY® Molecules

LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to o...

December 05, 2025 | Friday | News
Insulet Receives FDA Clearance for Major Omnipod 5 Algorithm Upgrade Featuring New 100 mg/dL Target Glucose Setting

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mo...

December 05, 2025 | Friday | News
VANUDIS Implements Cenevo Labguru to Scale Operations and Strengthen Regulatory Readiness

VANUDIS, a biotechnology startup developing the next generation of antibody-based therapeutics, has implemented Cenevo’s Labguru solution to scale ...

December 04, 2025 | Thursday | News
Rentschler Biopharma and Coriolis Pharma Announce Strategic Collaboration to Deliver Seamless, End-to-End Biopharmaceutical Development Solutions

The collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain Clien...

December 03, 2025 | Wednesday | News
Regeneron and Tessera Partner on One-Time Gene Writing Therapy for Alpha-1 Antitrypsin Deficiency

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by ...

December 02, 2025 | Tuesday | News
Imugene and JW Therapeutics Collaborate on Innovative CF33-CD19 and CAR-T Therapy for Solid Tumors

Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlyt...

December 01, 2025 | Monday | News
Eisai and Biogen Submit Subcutaneous Lecanemab (LEQEMBI®) Application to Japan’s PMDA

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachuse...

December 01, 2025 | Monday | News
SK Biopharmaceuticals Deepens Radiopharma Strategy With Exclusive License to WT-7695 From WARF

  New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partne...

November 28, 2025 | Friday | News
Sanyou Bio and FatiAbGen Forge Strategic Alliance to Accelerate Global Antibody Discovery

  Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a compre...

November 28, 2025 | Friday | News
Galux Demonstrates Precision AI Platform That Delivers Drug-Grade Antibodies in Weeks

-Galux, a South Korean biotech pioneering AI-driven protein therapeutics design, announced new experimental findings demonstrating that its AI protein de...

November 27, 2025 | Thursday | News
Avenzo Therapeutics Receives FDA Fast Track Designation for AVZO-103 in Urothelial Cancer

-Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, announced the U....

November 25, 2025 | Tuesday | News
Actimed and Mankind Pharma Sign Exclusive Licensing Deal for Cachexia Treatments in India and South Asia

Covers exclusive rights to S-pindolol, the novel therapy in development for the treatment of cachexia, in India and South Asia Represents a major step...

November 24, 2025 | Monday | News
NeuroThera Labs and Clearmind File Israeli Patent for Novel MEAI–PEA Combination Therapy Targeting Depression

SciSparc Ltd. announced that NeuroThera Labs Inc. , a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous sy...

November 21, 2025 | Friday | News
Alvotech and Advanz Pharma Secure EC Approval for Gobivaz®, the First Simponi® (golimumab) Biosimilar in Europe

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

November 21, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close